middle.news
Mayne Pharma’s DistributeRx Launch Drives Prescription Growth and Cash Surge
10:00am on Wednesday 29th of April, 2026 AEST
•
Healthcare
Read Story
Mayne Pharma’s DistributeRx Launch Drives Prescription Growth and Cash Surge
10:00am on Wednesday 29th of April, 2026 AEST
Key Points
DistributeRx prescriptions exceed forecasts by 72%
Women’s Health portfolio grows with BIJUVA® and NEXTSTELLIS®
Underlying EBITDA improves 57% to -$1.4 million
Adjusted operating cash flow nearly doubles to $28.3 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE